Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.
Hermine I BrunnerNikolay TzaribachevIngrid LouwInmaculada Calvo PenadesFrancisco Avila-ZapataGerd HorneffIvan FoeldvariDaniel J KingsburyMaria Eliana Paz GastanagaCarine WoutersJohannes BreedtRobert WongMargarita AskelsonJoe ZhuoAlberto MartiniDaniel J LovellNicolino Rupertonull nullPublished in: Arthritis care & research (2023)
Among individual patients with pJIA treated with abatacept who achieved one of the combined clinical and PRO composite endpoints, many maintained them over 21 months of abatacept treatment.